ElevateBio is a biotechnology company that develops and commercializes gene and cell therapies. The company's platform includes a portfolio of companies that specialize in different areas of gene and cell therapy development, including manufacturing, clinical development, and commercialization. ElevateBio's goal is to accelerate the development of gene and cell therapies to address unmet medical needs. The company was founded in 2019 by David Hallal and Nina Kjellson, two experienced biotech executives.